World markets had been greeting the prospect of a clear win for Joe Biden in the U.S. presidential election as a positive for stocks and bonds as it reduced electoral uncertainty and would likely ease global trade tensions but not succeed in a mega fiscal boost due to probable gridlock in Congress. But Pfizer and Germany's BioNTech's claim that their COVID-19 vaccine was more than 90% effective and ready to go to production both accelerated some of the S&P500, global and emerging market stock market moves as well as knocking back sharply havens such as T-bonds, gold and even the tech-heavy Nasdaq that has thrived on pandemic lockdowns.
Chart by Ritvik Carvalho and commentary by Mike Dolan
If you liked this, do consider subscribing. It’s free, and delivered to your inbox daily!